During the past decade, Herzzentrum Universitat Leipzig conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Herzzentrum Universitat Leipzig" #1 sponsor was "Boston Scientific Corporation" with 7 trials, followed by "Biotronik SE & Co. KG" with 2 trials sponsored, "ResMed" with 2 trials sponsored, "A. M. Zeiher" with 1 trials sponsored and "Miltenyi Biotec B.V. & Co. KG" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Herzzentrum Universitat Leipzig" #1 collaborator was "Blutspendedienst Baden-Württemberg - Hessen" with 1 trials as a collaborator, "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator, "Cardialysis BV" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "German Federal Ministry of Education and Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Herzzentrum Universitat Leipzig" are "Coronary Artery Disease" (3 trials), "Ventricular Tachycardia" (3 trials), "Aortic Valve Stenosis" (2 trials), "Congestive Heart Failure" (2 trials) and "Ventricular Fibrillation" (2 trials). Many other conditions were trialed in "Herzzentrum Universitat Leipzig" in a lesser frequency.

Most popular intervention types in "Herzzentrum Universitat Leipzig" are "Device" (11 trials), "Drug" (3 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin" (1 trials), "CD133+ autologous bone marrow stem cell" (1 trials), "Coronary Artery Bypass Surgery" (1 trials), "Europe: AutoSet CS (USA: VPAP Adapt SV)" (1 trials) and "ICD or CRT-D with Home Monitoring feature activated" (1 trials). Other intervention names were less common.

The vast majority of trials in "Herzzentrum Universitat Leipzig" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Herzzentrum Universitat Leipzig". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Herzzentrum Universitat Leipzig, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Herzzentrum Universitat Leipzig, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".